Rockefeller Capital Management’s Concentrix CNXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$112K Sell
5,008
-19
-0.4% -$496 ﹤0.01% 2927
2026
Q1
$138K Buy
5,027
+4,609
+1,103% +$164K ﹤0.01% 2692
2025
Q4
$17.4K Sell
418
-1,443
-78% -$58.5K ﹤0.01% 3572
2025
Q3
$85.9K Buy
+1,861
New +$99.3K ﹤0.01% 2644
2023
Q1
Sell
-30
Closed -$4K 2336
2022
Q4
$4K Hold
30
﹤0.01% 3366
2022
Q3
$3K Sell
30
-29
-49% -$3.71K ﹤0.01% 3466
2022
Q2
$8K Buy
59
+9
+18% +$1.35K ﹤0.01% 3220
2022
Q1
$8K Sell
50
-222
-82% -$42.2K ﹤0.01% 3150
2021
Q4
$47K Buy
272
+110
+68% +$19.6K ﹤0.01% 2248
2021
Q3
$28K Hold
162
﹤0.01% 2424
2021
Q2
$25K Buy
162
+35
+28% +$5.38K ﹤0.01% 2383
2021
Q1
$19K Buy
127
+50
+65% +$6.06K ﹤0.01% 2297
2020
Q4
$7K Buy
+77
New +$7.7K ﹤0.01% 2328

Other funds holding CNXC

Rockefeller Capital Management's CNXC Position: Q2 2026 in Review

Rockefeller Capital Management reduced its Concentrix (CNXC) stake by 0.38% in Q2 2026, selling an estimated $496 and leaving 5,008 shares worth $112K. The position accounts for ﹤0.01% of the portfolio, ranked #2927.

Rockefeller Capital Management first reported a position in CNXC in Q4 2020 and has held it in 13 quarters since. The position peaked at $138K in Q1 2026. 271 funds tracked by Wall St. Rank hold CNXC as of Q2 2026.

  • Rockefeller Capital Management held 5,008 shares of Concentrix worth $112K as of Q2 2026.
  • Rockefeller Capital Management sold 19 Concentrix shares in Q2 2026, an estimated $496.
  • Concentrix made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #2927 holding.
  • Rockefeller Capital Management first reported a position in Concentrix in Q4 2020 and has held it in 13 quarters since.
  • Rockefeller Capital Management's Concentrix position peaked at $138K in Q1 2026.
  • 271 funds tracked by Wall St. Rank held Concentrix as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.